Glaxo CFO Says Prioritizing R&D for Product Growth
Interactive Video
•
Business, Social Studies
•
University
•
Practice Problem
•
Hard
Wayground Content
FREE Resource
The transcript discusses the perception of Glaxo as uninspiring and the company's disagreement with this view. It highlights the progress made in recent quarters, focusing on new launches in respiratory, HIV, and vaccines, as well as cost savings and restructuring efforts. The company emphasizes its focus on R&D prioritization to drive significant product launches and outlines upcoming key launches, including treatments for shingles and HIV.
Read more
2 questions
Show all answers
1.
OPEN ENDED QUESTION
3 mins • 1 pt
What is the speaker's stance on the description of the company as 'uninspiring'?
Evaluate responses using AI:
OFF
2.
OPEN ENDED QUESTION
3 mins • 1 pt
What does the speaker suggest about the past range of launches?
Evaluate responses using AI:
OFF
Access all questions and much more by creating a free account
Create resources
Host any resource
Get auto-graded reports
Continue with Google
Continue with Email
Continue with Classlink
Continue with Clever
or continue with
Microsoft
%20(1).png)
Apple
Others
Already have an account?
